Clinical trial
A Randomised Clinical Trial of the Effect of Interleukin-1 Receptor Antagonism on the Insulin Production in Patients With New Onset Type 1 Diabetes
NCT00711503 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Clinical Trial of the Effect of Interleukin-1 Receptor Antagonism on the Insulin Production in Patients With New Onset Type 1 Diabetes
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- June 30, 2012
- Enrollment
- 69 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes